Correlation Between CannaPharmaRx and Cannabis Suisse

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both CannaPharmaRx and Cannabis Suisse at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining CannaPharmaRx and Cannabis Suisse into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between CannaPharmaRx and Cannabis Suisse Corp, you can compare the effects of market volatilities on CannaPharmaRx and Cannabis Suisse and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in CannaPharmaRx with a short position of Cannabis Suisse. Check out your portfolio center. Please also check ongoing floating volatility patterns of CannaPharmaRx and Cannabis Suisse.

Diversification Opportunities for CannaPharmaRx and Cannabis Suisse

-0.24
  Correlation Coefficient

Very good diversification

The 3 months correlation between CannaPharmaRx and Cannabis is -0.24. Overlapping area represents the amount of risk that can be diversified away by holding CannaPharmaRx and Cannabis Suisse Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cannabis Suisse Corp and CannaPharmaRx is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on CannaPharmaRx are associated (or correlated) with Cannabis Suisse. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cannabis Suisse Corp has no effect on the direction of CannaPharmaRx i.e., CannaPharmaRx and Cannabis Suisse go up and down completely randomly.

Pair Corralation between CannaPharmaRx and Cannabis Suisse

Given the investment horizon of 90 days CannaPharmaRx is expected to generate 3.79 times less return on investment than Cannabis Suisse. But when comparing it to its historical volatility, CannaPharmaRx is 2.19 times less risky than Cannabis Suisse. It trades about 0.07 of its potential returns per unit of risk. Cannabis Suisse Corp is currently generating about 0.12 of returns per unit of risk over similar time horizon. If you would invest  1.80  in Cannabis Suisse Corp on May 16, 2025 and sell it today you would lose (0.37) from holding Cannabis Suisse Corp or give up 20.56% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy98.39%
ValuesDaily Returns

CannaPharmaRx  vs.  Cannabis Suisse Corp

 Performance 
       Timeline  
CannaPharmaRx 

Risk-Adjusted Performance

Mild

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in CannaPharmaRx are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of rather unfluctuating primary indicators, CannaPharmaRx exhibited solid returns over the last few months and may actually be approaching a breakup point.
Cannabis Suisse Corp 

Risk-Adjusted Performance

Fair

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Cannabis Suisse Corp are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. Despite fairly unfluctuating basic indicators, Cannabis Suisse demonstrated solid returns over the last few months and may actually be approaching a breakup point.

CannaPharmaRx and Cannabis Suisse Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with CannaPharmaRx and Cannabis Suisse

The main advantage of trading using opposite CannaPharmaRx and Cannabis Suisse positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if CannaPharmaRx position performs unexpectedly, Cannabis Suisse can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cannabis Suisse will offset losses from the drop in Cannabis Suisse's long position.
The idea behind CannaPharmaRx and Cannabis Suisse Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.

Other Complementary Tools

Equity Valuation
Check real value of public entities based on technical and fundamental data
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.